Pharmacovigilance Scientist at AVEO Oncology Boston, MA

kozmetickesluzby.vecnakraska.sk - Jobboard; Boston (MA); On-site; USD 85,000 - 120,000; Full time

Job summary

AVEO is seeking a PV Scientist in Boston, Massachusetts to support clinical safety through safety surveillance and regulatory reporting. This role involves developing signal management tools and collaborating with cross-functional teams to ensure compliance with pharmacovigilance regulations.

The ideal candidate will have an advanced degree in a life sciences field and significant experience in safety analysis and signal detection. This position is part-time, requiring on-site attendance three days a week.

Qualifications

• Advanced degree in a life sciences-related field preferred.
• Significant experience in pharmacovigilance or related discipline.
• Strong expertise in safety data analysis and signal detection.

Responsibilities

• Provide review and input for responses to Regulatory Authorities.
• Develop tools for signal management activities.
• Conduct evaluations of safety signals and prepare reports.
• Attend multidisciplinary project team meetings.

Skills

Safety data analysis

Signal detection

Regulatory reporting

Cross-functional collaboration

Communication skills

Education

Advanced degree (PharmD, PhD, MD)

Tools

Safety databases

EDC systems

Job description

Job Summary

The PV Scientist will play a key role in safety surveillance, signal detection, and regulatory reporting. This individual will collaborate cross‑functionally to support clinical and post‑market safety activities, ensuring compliance with global pharmacovigilance regulations and company policies. This role is 3 days a week on‑site.

Principal Duties

• Regulatory Support:
  • Provide review and input for responses to Regulatory Authorities.
• Data Analytics & Signal Management:
  • Develop, refine, and utilize data analytic tools for signal management activities.
  • Contribute to safety signal surveillance, evaluation, and analysis.
  • Develop and implement project‑specific signal detection strategies.
  • Conduct in‑depth evaluations of safety signals and prepare analysis reports.
  • Lead strategy and preparation for quarterly ad hoc safety committee meetings, including presentation materials and communication.
• Clinical Safety Assessments:
  • Provide safety input and review of Clinical Study Reports (CSRs), Statistical Analysis Plans (SAPs), and Tables, Listings and Figures (TLFs).
  • Draft safety sections for top‑line results, key safety messages, and assist in writing safety narratives.
  • Perform Individual Case Safety Report (ICSR) review for clinical trials and post‑market programs.
  • Generate Analysis of Similar Events (AOSE) outputs and draft AOSEs for clinical trials.
• Cross‑Functional Collaboration & Medical Review:
  • Attend multidisciplinary project team meetings and serve as the PV Scientist lead in medical monitor meetings.
  • Provide PV medical support for key safety‑related documents, including:
    • Informed Consent Forms (ICF)
    • Protocols
    • Investigator’s Brochure (IB) / Reference Safety Information (RSI) documents
    • Aggregate Report reviews
    • Case Report Form (CRF) page reviews
    • Clinical coding reviews
    • Literature extracts for medical affairs
    • Safety Management Plans (SMP)
    • Safety Reporting Plans
    • Medical Monitor Plans
    • Standard Operating Procedures (SOPs)

Required Qualifications / Experience (Basic Qualifications)

• Advanced degree (PharmD, PhD, MD, or equivalent) in a life sciences‑related field preferred.
• Significant experience in pharmacovigilance, safety surveillance, or related discipline.
• Strong expertise in safety data analysis, signal detection, and regulatory reporting.
• Proficiency in safety databases, EDC systems, and case processing tools.
• Excellent communication and leadership skills, with the ability to work cross‑functionally.

About AVEO
AVEO is a commercial‑stage, oncology‑focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer. AVEO currently markets FOTIVDA® (tivozanib) in the U.S. for the treatment of adult patients with relapsed or refractory renal cell carcinoma (RCC) following two or more prior systemic therapies. AVEO continues to develop FOTIVDA in immuno‑oncology combinations in RCC and other indications, and has several other investigational programs in clinical development. AVEO is committed to creating an environment of diversity, equity and inclusion to diversify representation within the Company. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.